This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers

NEW YORK (TheStreet) - I define stocks that qualify as stocking stuffers as those with a buy rating according to, are more than 20% undervalued, have an average daily trading volume of at least 200,000 shares and projected to gain at least 7.5% over the next 12 months. Headlining this screening are Advanced Micro Devices (AMD - Get Report) and Alaska Communications (ALSK - Get Report) along with seven others.

I never profile a penny stock as these stocks trade below a buck a share and they do so for a reason.

I consider stocks trading between a buck a share and $3 a share as 'options on survival' if they have a buy rating according to ValuEngine. When you buy the stock within this price range you have the risk that it may become worthless vs. the possibility that the stock price could double, triple or more in price.

When a stock is trading below $5 a share individuals cannot buy that company on margin. Three of the stocks in today's post trade between $3 and $5 so these stocks have a higher cost for that 'option on survival.'

Must Read: 4 Stocks Rising With Big Volume

If you buy a stock considered an 'option on survival' consider it a Christmas stocking stuffer and look at it a year from now to see if you made money, but beware that the risk is that the stock has become a lump of coal.

My buy-and-trade profiles are based upon fundamental data that determines ratings and valuations including 12 month trailing earnings per share, 12 month forward estimates of earnings per share and on the yield on the Treasury 30-Year bond. ValuEngine can not anticipate positive or negative company specific events which can affect the performance of low-priced stocks particularly among biotech companies.

Alterna Zentars (AEZS)($1.20) is a biotech company focusing on treatments for prostate issues for men and ovarian issues for women. The stock has a buy rating is 75% undervalued and is down 47.9% over the last 12 months and is below its 200-day simple moving average at $1.53. This stock recently declined from $1.74 on Nov. 15 to 99 cents on Nov. 20. My weekly value level is $1.11 with a month pivot at $1.18 and semiannual and quarterly risky levels at $1.39 and $1.60.

Alaska Communications ($2.17) provides local telephone, wireless and Internet services to subscribers in Alaska. The stock has a buy rating is 39.5% undervalued with a gain of 6.9% over the last 12 months and is just below its 200-day SMA at $2.21. This stock traded as high as $3.90 on August 8 and was above $16 in mid-2007. This week's value level is $1.80 with a monthly risky level at $2.74.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALSK $1.75 -1.10%
AMD $3.62 -3.30%
AAPL $94.00 0.38%
FB $118.01 -0.47%
GOOG $696.66 -0.22%


Chart of I:DJI
DOW 17,708.51 -182.65 -1.02%
S&P 500 2,060.14 -21.29 -1.02%
NASDAQ 4,765.0240 -52.57 -1.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs